ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent diseaseNicoletta Colombo, Jonathan A. Ledermann, W. Glenn McCluggage et al.|Annals of Oncology|2019Cited by 1.2k
Low meprin α expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovariesViola Heinzelmann‐Schwarz, Philippa M. O’Brien|Journal of Clinical Pathology|2006Cited by 25
Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancerRicardo Coelho, Viola Heinzelmann‐Schwarz|Cell Death and Disease|2022Cited by 24
Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell linesAndré Fedier, Viola Heinzelmann‐Schwarz|International Journal of Oncology|2022Cited by 9
De novo detection of somatic variants in high-quality long-read single-cell RNA sequencing dataArthur Dondi, Niko Beerenwinkel, Nico Borgsmüller et al.|Genome Research|2025Cited by 6